Department of Radiology

Publications

2019

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019;142(1):133-145.

Guo Y, Liu Z, Wen Y, Spincemaille P, Zhang H, Jafari R, et al. Quantitative susceptibility mapping of the spine using in-phase echoes to initialize inhomogeneous field and R2* for the nonconvex optimization problem of fat-water separation. NMR Biomed. 2019;32(11):e4156.

Moghadam AA, Caprio A, Alaie S, Min JK, Dunham S, Mosadegh B. Rapid Manufacturing of Thin Soft Pneumatic Actuators and Robots. J Vis Exp. 2019;(153).

S Bandt K, de Rochefort L, Chen W, Dimov AV, Spincemaille P, Kopell BH, et al. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice. World Neurosurg. 2019;122:e10-e19.

Miyata M, Kakeda S, Kudo K, Iwata S, Tanaka Y, Wang Y, et al. Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping. J Cereb Blood Flow Metab. 2019;39(8):1648-1658.

Byron K, Winkler SA, Robb F, Vasanawala S, Pauly J, Scott G. An MRI Compatible RF MEMs Controlled Wireless Power Transfer System. IEEE Trans Microw Theory Tech. 2019;67(5):1717-1726.

Niogi SN, Luther N, Kutner K, Shetty T, McCrea HJ, Barnes R, et al. Increased sensitivity to traumatic axonal injury on postconcussion diffusion tensor imaging scans in National Football League players by using premorbid baseline scans. J Neurosurg. 2019:1-9.

Kobayashi M, Benakis C, Anderson C, Moore MJ, Poon C, Uekawa K, et al. AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke. Cell Rep. 2019;28(4):979-991.e6.

Varangis E, Razlighi Q, Habeck CG, Fisher Z, Stern Y. Between-network Functional Connectivity Is Modified by Age and Cognitive Task Domain. J Cogn Neurosci. 2019;31(4):607-622.

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, et al. Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). J Alzheimers Dis. 2019;67(2):685-705.